PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsUrinary bladder diseases
MeSH D001745 - urinary bladder diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D014570:Urologic diseases
0 Companies
0 Drugs
Success rate
D001745: 
Urinary bladder diseases
66 Companies
15 Drugs
$
Success rate
D000077295:Underactive urinary bladder
0 Companies
0 Drugs
Success rate
D001744:Urinary bladder calculi
0 Companies
0 Drugs
Success rate
D001746:Bladder exstrophy
0 Companies
0 Drugs
Success rate
D001747:Urinary bladder fistula
0 Companies
0 Drugs
Success rate
D001748:Urinary bladder neck obstruction
7 Companies
1 Drug
$
Success rate
D001749:Urinary bladder neoplasms
53 Companies
14 Drugs
$
Success rate
D001750:Neurogenic urinary bladder
51 Companies
3 Drugs
$
Success rate
D003556:Cystitis
84 Companies
14 Drugs
$
Success rate
D014718:Vesico-ureteral reflux
0 Companies
0 Drugs
Success rate
D052858:Cystocele
0 Companies
0 Drugs
Success rate
D053201:Overactive urinary bladder
42 Companies
8 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaTolterodine Tolterodine  2015-02-23   
PadagisHydrocortisone, Bacitracin, Neomycin, Polymyxin b Bacitracin-neomycin-polymyxin W/ Hydrocortisone  1982-01-01   
MylanTolterodine Tolterodine  2012-11-27   
SandozHydrocortisone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Hydrocortisone  1983-08-25   
Bausch Health CompaniesHydrocortisone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Hydrocortisone  1995-12-29   
Hydrocortisone, Bacitracin, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates, Bacitracin Hydrocortisone  1995-10-30   
Hydrocortisone, Neomycin, Polymyxin b Oticair  1996-08-28   
Merck & CoHydrocortisone, Neomycin, Polymyxin b Otobione  1982-01-01   
Hydrocortisone, Polymyxin b Otobiotic  1982-01-01   
AllerganHydrocortisone, Neomycin, Polymyxin b Otocort  1982-01-01   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
75%
3/4
Phase 2
22%
2/9
Phase 3
50%
4/8
Approved: 4Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Tolterodine
GSK
Neomycin
Novartis
Dexamethasone,
SAF312
Bausch Health Companies
Dexamethasone,
Hydrocortisone,
Neomycin,
Polymyxin b,
Trimethoprim
Merck & Co
Hydrocortisone,
Hydrocortisone butyrate,
Hydrocortisone probutate,
Neomycin,
Polymyxin b
Allergan
Hydrocortisone,
Prednisolone,
Hydrocortisone probutate,
Hydrocortisone butyrate,
Prednisolone tebutate,
Albumin,
Ademetionine,
Sodium chloride,
Azzalure
Pfizer
Polymyxin b,
Bevifimod,
Gemcis
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use